finnCap - Avacta, Initiation of coverage
FCAP Thu, 20 Oct 2016, 08:41am BST
finnCap initiate coverage on Avacta, the preclinical stage biopharmaceutical company. finnCap initiate with a 12-month target price of 200p, implying an EV of c£125m/$150m, which they expect to be reached as the company meets its key identified technical preclinical and commercial milestones.
Jonathan Bright, Digital Content Marketing Manager
Thu, 23 Apr 2020, 10:00am BST
Sam Smith, CEO, finnCap
Thu, 27 Dec 2018, 10:00am GMT
Ambition Nation,
Thu, 1 Feb 2018, 10:00am GMT
Sam Smith, CEO, finnCap
Wed, 27 Dec 2017, 2:00pm GMT
Sam Smith, CEO, finnCap
Fri, 1 Dec 2017, 12:20pm GMT
Sam Smith, CEO, finnCap
Fri, 1 Dec 2017, 12:15pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:10pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:05pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:00pm GMT
Stuart Andrews, Head of Corporate Finance
Tue, 24 Oct 2017, 2:32pm BST
Stuart Andrews, Head of Corporate Finance
Tue, 24 Oct 2017, 2:31pm BST
Funding Tech Disruptors
Tue, 24 Oct 2017, 2:30pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:20pm BST
Sam Smith, CEO, finnCap
Mon, 2 Oct 2017, 12:15pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:10pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:05pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:00pm BST
David Buxton, Analyst
Wed, 26 Jul 2017, 1:55pm BST